Alignment Healthcare, Inc. (ALHC) · Oct 8, 2026 · Other events
3.5-Star rating — H3815 falls from 4.0 to 3.5 Stars; serves ~75% of membership
Alignment Healthcare’s Star Ratings filing shows its largest California plan falling to 3.5 Stars, creating a 2028 bonus-payment headwind.
Alignment is a fast-growing Medicare Advantage platform using its clinical model and technology to mature member profitability; membership reached approximately 294,100 by June 30, 2026, up 31.5% year over year. The filing interrupts that growth-and-margin story with a quality setback. CMS’s 2027 rating puts H3815, Alignment’s core California HMO contract, at 3.5 Stars versus 4.0 Stars for 2026, and that contract serves approximately 75% of membership. 〔0〕
The impact is delayed, not absent. Alignment says the rating change will not affect fiscal 2026 or 2027 revenue, but it will reduce quality bonus payments in fiscal 2028. Provider risk-sharing arrangements may offset part of the hit, but the filing does not quantify the remaining exposure. 〔1〕
This is worse than the standing expectation of maintaining the prior rating. There is no earnings-consensus benchmark to score here; the clean comparison is the company’s previous 4.0-Star position and its established emphasis on high-quality, profitable growth. The other six eligible plans are expected to remain at 4.0 Stars or higher, which limits the damage, but H3815’s 75% membership exposure makes the downgrade material. 〔2〕
The explanation points to an operating challenge, not merely a reporting technicality. Alignment attributes the decline primarily to higher industry cut points and weaker performance on triple-weighted Health Outcomes Survey and Part D measures. It also says CMS’s retroactive removal of health-equity bonus calculations reduced the payoff from prior investments, but the core issue remains that the largest contract no longer clears the 4-Star threshold. 〔3〕
Management has a recovery plan, but it is not yet evidence of recovery. The company cites stronger member and provider engagement, expanded care-gap closure, quality oversight, administrative appeals and planned litigation. With roughly half of membership joining within the last two years, the company argues that member maturation can still support margins, but that offsets a known future headwind rather than removing it. 〔4〕
Bottom line: This is a meaningful negative change to Alignment’s quality-and-margin story, concentrated in its largest plan but financially deferred until 2028. The appeals may soften or reverse the outcome, yet the filing currently leaves the company needing to rebuild its core contract’s rating while absorbing a future bonus-payment risk.structured
CMS appeals and litigation over disputed rating calculations
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!